26/10/2026
🇺🇸 US FDA Cleared & 🇪🇺 EU IVDR Compliant!
We are pleased to announce that the Liofilchem® Gepotidacin GEP 10 μg Antibiotic Disc has achieved both regulatory milestones, further strengthening our in vitro diagnostic portfolio.
Designed for clinical microbiology laboratories, this product provides a standardized, semi-quantitative method for antimicrobial susceptibility testing (AST) using agar disc diffusion.
Gepotidacin is a novel antimicrobial agent belonging to the triazaacenaphthylene class, representing an important addition to the available therapeutic options against bacterial infections.
The GEP 10 μg disc is intended for susceptibility testing of the following organisms:
🔬 Enterobacterales
🔬 E. faecalis
🔬 S. saprophyticus
🏅 FDA clearance and EU IVDR compliance demonstrate Liofilchem’s ongoing commitment to innovation, quality, and reliable diagnostic solutions, empowering clinical laboratories to support informed antimicrobial treatment decisions and contribute to the global fight against antimicrobial resistance.
📦 Gepotidacin GEP 10 μg Antibiotic Disc – Available Formats:
-Ref. 9256 – 5 individually packed cartridges × 50 discs
-Ref. 9256/1 – 1 cartridge × 50 discs
-Ref. 9256/2 – 1 canister pack containing 250 discs